Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
Mark Heyland, Researcher at Berlin Metropolitan Area, shared a post on LinkedIn about recent articles, adding:
“Moving Beyond Mechanics:
The Thromboinflammatory Frontier in Fracture Healing
How do we predict and prevent atrophic fracture non union when mechanical fixation is clinically perfect?
The answer lies deep within biological cross talk, specifically at the intersection of the coagulation and complement cascades.
Two recent studies highlight an evolving perspective in orthopedic care and therapeutic design:
๐๐ก๐ ๐๐ฅ๐จ๐ญ๐ญ๐ข๐ง๐ ๐๐ข๐ง๐ค: ๐๐ฅ๐๐ฏ๐๐ญ๐๐ ๐
๐ข๐๐ซ๐ข๐ง๐จ๐ ๐๐ง
A study recently published in Frontiers in Surgery underscores a critical biological hurdle:
๐ ๐ข๐ง๐๐ข๐ง๐ : High plasma fibrinogen levels independently drive non-union risk.
๐๐๐๐ก๐๐ง๐ข๐ฌ๐ฆ: Altered extracellular matrix deposition actively restricts local angiogenesis.
(Published as part of our Research Topic, ‘Innovations in Fracture Fixation and Rehabilitation: Bridging the Gap in Orthopedic Care’)
๐๐ก๐ ๐๐ฆ๐ฆ๐ฎ๐ง๐ ๐๐ข๐ง๐ค: ๐๐ฎ๐ฌ๐ญ๐๐ข๐ง๐๐ ๐๐๐๐1 ๐๐๐ญ๐ข๐ฏ๐๐ญ๐ข๐จ๐ง
Parallel research in Frontiers in Immunology uncovers the innate immune side of the equation:
๐ ๐ข๐ง๐๐ข๐ง๐ : Systemic MASP1 levels are significantly elevated in atrophic non-union.
๐๐๐๐ก๐๐ง๐ข๐ฌ๐ฆ: Chronic lectin pathway activation correlates directly with impaired tissue repair.
๐๐ก๐ ๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐๐ซ๐ญ๐ก๐จ๐ฉ๐๐๐ข๐ ๐๐ก๐๐ซ๐๐ฉ๐ข๐๐ฌ
These findings expose a dual threat environment of thromboinflammation, where persistent biochemical stress disrupts microvascular invasion and early osteogenesis. Moving forward, therapeutic design must address both axes:
๐๐ฎ๐๐ฅ ๐๐๐ซ๐ข๐ง๐ ๐๐ซ๐จ๐ญ๐๐๐ฌ๐ ๐๐จ๐๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง: Utilizing regulators like C1 esterase inhibitor (C1 INH) to simultaneously block complement activation (MASP1) and dampen upstream hypercoagulability.
๐๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐๐ง๐ญ๐ข๐ญ๐ก๐ซ๐จ๐ฆ๐๐จ๐ญ๐ข๐ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ: Exploring localized or dose titrated Low Molecular Weight Heparin (LMWH) delivery to mitigate microvascular thrombosis without disrupting early hematoma stability.
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ฆ๐จ๐๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐ข๐จ๐ฆ๐๐ญ๐๐ซ๐ข๐๐ฅ๐ฌ: Designing smart, localized scaffolds that actively resolve chronic thromboinflammatory signals and restore a pro-regenerative niche.
True personalization in orthopedics requires bridging the gap between mechanical stability and systemic biology.
Explore the research”
Title 1: Association between fibrinogen concentration and nonunion in fracture patients
Authors: Lili Geng, Zejun Wang, Jinlei Dong, Bingru Lu, Jincan Wang, Yuqin Wang, Yiqing Liu
Read the Full Article on Frontiers in Surgery, Orthopedic Surgery
Title 2: Serum complement system activation in normal healing and atrophic non-union of human long bone fractures
Authors: Yasser M. El-Sherbiny, Youssif M. Ali, Elena Jones, Peter V. Giannoudis, Jehan J. El-Jawhari
Read the Full article on Frontiers in Immunology, Inflammation
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1โHepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment